PEMBROLIZUMAB , NIVOLUMAB , IPILIMUMAB
CO2MO
Approved small_molecule active
Quick answer
PEMBROLIZUMAB , NIVOLUMAB , IPILIMUMAB for Melanoma is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Melanoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active